The P210bcr/a'M protein is associated with virtually every case of human chronic myelogenous leukemia.
The p210bcr/abl protein derives from a hybrid gene created by the chromosomal translocation that generates the Philadelphia chromosome, a cytogenetic abnormality which characterizes human chronic myelogenous leukemia (CML) cells (1) . The CML-specific P210 protein shares structural and enzymatic properties with the v-abl protein of the Abelson murine leukemia virus (A-MuLV). The gene for P210 and v-abl arose by substitution of the c-abl* sequence encoding the N-terminal region with bcr (2) and helper-virus-derived gag sequences (3), respectively. Both proteins exhibit elevated tyrosine-specific protein kinase activity (4) . The v-abl protein is responsible for the induction of acute lymphosarcomas in susceptible murine hosts infected with A-MuLV (5) . The role of P210 in the etiology of human CML remains to be defined.
The v-abl protein can transform a variety of cell types. It efficiently transforms NIH 3T3 fibroblasts in vitro (6) and pre-B-lymphoid cells both in vitro and in vivo (7) and is able to relieve the growth-factor dependence of several hematopoietic cell types, including T-cell lines dependent on interleukin 2 (8) , and various interleukin 3 (IL-3)-dependent lymphoid and myeloid cell lines (9) (10) (11) (12) (13) . Unlike v-abl, P210 does not transform NIH 3T3 fibroblasts (14) . In this study, we demonstrate that P210 resembles v-abl in its ability to transform the IL-3-dependent hematopoietic cell line Ba/F3 (15) to factor independence and tumorigenicity. These experiments demonstrate the oncogenic potential of P210br/abl.
MATERIALS AND METHODS
Plasmid Constructs, Viral Stocks, and Cell Culture Conditions. A 4.7-kilobase (kb) fragment containing coding sequence for the full-length P160 isolate of v-abl (16) was cloned into the BamHI cloning site of the pWE vector (B. Guild and R. C. Mulligan, Whitehead Institute) by using BamHI linkers. The resulting size for the pWEgab construct was 8.7 kb from the 5' long terminal repeat (LTR) to the 3' LTR. The full-length P210b~r/abl cDNA 172/215 (17) was cloned into pWE by using Bcl I linkers. The resulting LTR-LTR size for the pWE210 construct was 11 kb. Viral stocks were generated by the following methods. Replication-competent retroviral complexes were made by cotransfection of the constructs with helper Moloney murine leukemia virus DNA (pZAP, ref. 18) onto NIH 3T3 cells. Alternatively, helper-free retroviral stocks were made by transfecting the constructs onto the packaging line qi-2 (19) and infecting tunicamycintreated q-2 cells with a transient viral harvest from the transfected qi-2 cells. Retroviral supernatants from G418-resistant producer populations were harvested after 18 hr and passed through a 0.45-,um filter. Viral supernatants were titered for G418 resistance by infection of NIH 3T3 fibroblasts. All retroviral producer cell lines had comparable titers in the range of 105 G418-resistant colony-forming units/ml. Ba/F3 is a murine bone marrow-derived cell line dependent on IL-3 for viability and proliferation (15) . IgG was preincubated with conditioned medium for 1 hr prior to addition to the proliferation assay. Nucleic Acid and Protein Analysis. High molecular weight genomic DNA was isolated from relevant cell lines, digested with the enzyme Xba I, electrophoresed through a 0.7% agarose gel, transferred to a nylon membrane, and probed with a fragment of the G418-resistance (Neo) gene labeled to high specific activity (>109 cpm/Ag). Hybridization and wash conditions were of high stringency. Immunoprecipitation analysis of abl proteins was as described (22) .
Assay of Tumorigenicity in Nude Mice. Cells for assay of tumorigenicity were washed with serum-free medium and resuspended in Hanks' balanced saline solution. About 2 x 106 cells were injected subcutaneously into young (<12 week old) nude mice (BALB/c-AnNCr-nu) from the National Cancer Institute. Mice received 500 rads (1 rad = 0.001 Gy) of y-irradiation 24 hr prior to cell challenge. Mice were observed for 2-3 months for signs ofpalpable or visible tumor at the site of injection. Tumorigenic cell lines gave rise to a visible pea-sized mass with a short latency after injection which was nonregressing and malignant. Nontumorigenic cell lines showed no evidence of tumor for up to 3 months after injection.
RESULTS Constructs for expression of abl protein variants were made by using the pWE vector ( Fig. 1) . The pWE vector carries a dominant coselectable antibiotic-resistance marker expressed from the promoter element of the Moloney virus LTR. The cloned abl sequence is expressed from an internal promoter derived from the chicken p-actin gene. Titers of retroviral producer cell supernatants were determined by resistance of infected NIH 3T3 fibroblasts to the antibiotic G418 and were comparable for all constructs (105 colonyforming units/ml). IL-3-dependent Ba/F3 cells were infected with retroviral-producer cell culture supernatants and grown for 48 hr in the presence of WEHI-3B conditioned medium prior to selection (Fig. 2) . Primary selection for viral infection was carried out in medium supplemented with both WEHI-3B conditioned medium and G418 at 2 mg/ml. For all infected cell lines, G418-resistant populations arose after 7-10 days of selection, suggesting that -0.1% of cells had been infected. To select for IL-3 independence, G418-resistant populations were washed extensively with PBS and cultured in medium lacking a source of IL-3. Cell populations infected with the pWE210 virus (encoding p210bcr/abl) or the pWEgab virus (encoding P1605ag/V-abl) gave rise to populations of IL-3-independent cells after 5-10 days, suggesting that between 0.1% and 5% of cells survived selection. A G418-resistant population of cells infected with the pWE virus alone or uninfected cells did not survive selection in medium lacking a source of IL-3, demonstrating that abl sequences are required to generate IL-3 independence (Table 1) .
Uninfected Ba/F3 cells proliferate maximally in the presence of 3-1o (vol/vol) conditioned medium from WEHI-3B cells, and their proliferation declines upon dilution of the conditioned medium (Fig. 3) . The proliferation profile for Ba/F3 cells infected with the pWE virus alone is similar to that for the uninfected Ba/F3 cell line (Fig. 3A) . Cells infected with viruses that encode P21Obcr/ab, or p16gag/v-ab1 and selected for growth in the absence of exogenous IL-3 proliferate in a factor-independent manner, without regard to the concentration of conditioned medium from WEHI-3B cells. Their growth rate is equivalent to the parental Ba/F3 cell line growing in medium supplemented with IL-3 (unpublished data). Conditioned medium from the IL-3-independent cell lines infected with either the pWE210 or pWEgab viruses will not support the proliferation of uninfected Ba/F3 cells.
This suggests that the pWE210-and pWEgab-infected cells do not liberate a growth factor into the medium that can support their growth by autocrine stimulation. Analysis of total RNA from the IL-3-independent cell lines failed to detect expression of IL-3 mRNA, although it could readily be detected in WEHI-3B cells (unpublished data). Fig. 3B shows the results of experiments with a specific antibody to IL-3 capable of neutralizing its growth-promoting activity. IgG directed at an irrelevant antigen (the epidermal growth factor receptor) failed to alter the proliferation profile for uninfected Ba/F3 cells. IgG specific for IL-3 inhibited the proliferative activity of WEHI-3B conditioned medium for uninfected Ba/F3 cells. The IL-3-independent Ba/F3 cells infected with either the pWE210 or pWEgab viruses were assayed in medium lacking WEHI-3B conditioned medium in the presence of neutralizing anti-IL-3 IgG. The proliferation of the pWE210-and pWEgab-infected cells was unaffected by the presence of the neutralizing IgG. Analysis of the proviral structure in the IL-3-independent cell lines showed the pWE210 and pWEgab viruses to be intact and unrearranged. Digestion of total genomic DNA with the restriction endonuclease Xba I, which cuts within the retroviral LTRs to expose the full-length provirus, demonstrated the expected fragment sizes for the relevant constructs (Fig. 4) . The correct proviral structure was detected by either the G418-resistance (Neo) gene or c-abl probe sequences (unpublished data). The provirus in these cell lines was rescued by superinfection with Moloney helper virus. Virus rescued from either pWE210-or pWEgab-infected IL-3-independent cell lines passed the G418-resistance marker upon (25) . The ability to detect the molecular rearrangement of bcr and abl in a proportion of the CML patients for whom cytogenetic evidence of the Philadelphia chromosome is lacking (26) further strengthens the association of the aberrant chromosome with the disease. The product of the Philadelphia chromosome, the P210bcr/abl fusion protein, resembles the P160sag/v-abl oncogene product in enzymatic and structural properties. The c-abl sequences that are deleted in the formation of P210 and P160 v-abl share homology with nonreceptor tyrosine kinases (e.g., src and fps), phospholipase C, and the avian v-crk oncogene (27, 28) . Simple deletion of this region within the c-abl type IV sequence is sufficient to activate the transforming potential of c-abl for fibroblasts and lymphoid cells (P. Jackson and D.B., unpublished results). The association of the Philadelphia For the capacity to establish Ba/F3 cell line under conditions of primary selection (G418 resistance) or secondary selection (IL-3 independence), + indicates establishment of continuously proliferating cell line and -indicates cell line will not grow under specified conditions. To establish whether infected cells could produce tumors in nude mice, the number of mice that developed large, nonregressing tumors at the site of subcutaneous injection of cells over the number of mice challenged is shown. To determine whether conditioned medium could support Ba/F3 cell proliferation, conditioned medium was harvested from helper-virus-free cell lines at high density and passed through a 0.45-,pm filter. These experiments establish the oncogenic potential of P210bcr/abl for the lymphoblastoid cell line Ba/F3. Preliminary results suggest that P210 will transform the IL-3-dependent mast cell line 32Dc13 to factor independence, thus demonstrating transformation for myeloid cell types (unpublished data). Unlike v-abl, P210 cannot transform NIH 3T3 fibroblasts unless it recombines with N-terminal gag sequences from the helper virus, which provides a myristoylation function critical for fibroblast transformation (14) .
Given that P210 will not transform fibroblasts, the requirements for transformation of adherent and nonadherent cell types by abl proteins appear to be distinct. 23 ) and processed for in vitro immune-complex kinase reaction as described (22) . Proteins were displayed by NaDodSO4/ polyacrylamide gel electrophoresis and visualized by autoradiography. Each lane was normalized for total protein content. Lanes: 1, pWE210-infected cells maintained in IL-3 prior to selection for IL-3 independence; 2, pWE210-infected cells selected for IL-3-independent growth; 3, pWEgab-infected cells maintained in IL-3 prior to selection for IL-3 independence; 4, pWEgab-infected cells selected for IL-3-independent growth.
